within Pharmacolibrary.Drugs.ATC.J;

model J05AB02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 3.3333333333333335e-07,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J05AB02</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Idoxuridine is a nucleoside analog of deoxyuridine, formerly used as an antiviral agent especially for the treatment of herpes simplex virus infections of the eye (herpetic keratitis). It is rarely used today due to the availability of safer and more effective antivirals. Idoxuridine is typically administered topically as eye drops or ointment.</p><h4>Pharmacokinetics</h4><p>No referenced studies report detailed pharmacokinetic parameters for idoxuridine in humans. Estimates are provided based on the compound's low systemic absorption and typical routes of administration.</p><h4>References</h4><ol><li><p>Marren, K (2011). Dimethyl sulfoxide: an effective penetration enhancer for topical administration of NSAIDs. <i>The Physician and sportsmedicine</i> 39(3) 75–82. DOI:<a href=&quot;https://doi.org/10.3810/psm.2011.09.1923&quot;>10.3810/psm.2011.09.1923</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22030943/&quot;>https://pubmed.ncbi.nlm.nih.gov/22030943</a></p></li><li><p>Seth, AK, et al., &amp; Umrigar, D (2004). Topical liposomal gel of idoxuridine for the treatment of herpes simplex: pharmaceutical and clinical implications. <i>Pharmaceutical development and technology</i> 9(3) 277–289. DOI:<a href=&quot;https://doi.org/10.1081/pdt-200031432&quot;>10.1081/pdt-200031432</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15458233/&quot;>https://pubmed.ncbi.nlm.nih.gov/15458233</a></p></li><li><p>Wagstaff, AJ, et al., &amp; Goa, KL (1994). Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. <i>Drugs</i> 47(1) 153–205. DOI:<a href=&quot;https://doi.org/10.2165/00003495-199447010-00009&quot;>10.2165/00003495-199447010-00009</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7510619/&quot;>https://pubmed.ncbi.nlm.nih.gov/7510619</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J05AB02;
